Description

Sprycel is a medication used primarily to treat certain types of leukemia, particularly chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). It works by inhibiting specific proteins that promote cancer cell growth, thereby helping to manage the disease.

Interpreter Notes

Interpreters should be aware that 'Sprycel' may be referred to by its generic name, dasatinib, in some contexts. It is important to maintain a formal register and avoid colloquial terms. Ensure clarity when discussing treatment options to prevent confusion with other cancer medications.

Example Sentences

EN: The doctor prescribed Sprycel to help manage the patient's chronic myeloid leukemia.

ES: El médico recetó Sprycel para ayudar a controlar la leucemia mieloide crónica del paciente.

Common Interpreter Mistakes

Confusing Sprycel with other leukemia medications; mispronouncing 'Sprycel' as 'spray-cel'; mixing up the generic name dasatinib with similar-sounding drugs.